Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Sunday, April 17<br />
Poster Session 8:30 a.m.–5:30 p.m.<br />
P2.153 Multiple Sclerosis, EDSS<br />
and Walking: Computerized Objective<br />
Gait Analysis of the Impact of a<br />
6-Minute Timed Walk on Selected Gait<br />
Characteristics in People with Multiple<br />
Sclerosis - Putting Long Legs on a Walking<br />
Scale —Christina Burke, Mark Gudesblatt,<br />
Karl Wissemann, Myassar Zarif, Barbara<br />
Bumstead, Lori Fafard, Smitha Thotam, John<br />
Magel, Marijean Buhse, Lisa Muratori<br />
P2.154 Improving MS Care with an<br />
International Videoconference-Based<br />
Provider Education and Case Consultation<br />
Program —Kevin Alschuler, Annette<br />
Wundes, Dennis Dietrich, Boskovski Bojan,<br />
Igor Kuzmanovski, Gloria Von Geldern,<br />
Katharine Alexander, Gary Stobbe<br />
P2.155 Does MRZ Reaction Have<br />
a Real Significance in the Diagnosis of<br />
Multiple Sclerosis? —Pavel Hradilek, David<br />
Zeman, Barbora Kurkova, Olga Zapletalova,<br />
Ivana Woznicova, Katarina Reguliova, Radim<br />
Piza<br />
P2.156 A Qualitative Assessment<br />
of Key Symptoms Associated with the<br />
Progression from RRMS to SPMS by<br />
Physicians and Patients —Bryan Bennett,<br />
Chloe Tolley, Sarah Kilgariff, Deniz Simsek,<br />
Raquel Lahoz, Elisabetta Verdun Di Cantogno,<br />
Tjalf Ziemssen<br />
P2.157 The Relationship Between the<br />
Clinical Condition of MS Patients and the<br />
Nutritional Status, Mitochondrial Activity<br />
and Oxidative Stress —Radi Shahien, Chen<br />
Waldman, Ayelet Omer Armon<br />
MS and CNS Inflammatory Disease:<br />
Treatment of NMO and Other CNS<br />
Diseases<br />
P2.158 Does Rituximab Cause<br />
Depletion of T-Cells in Multiple Sclerosis<br />
and Neuromyelitis Optica? —Paula<br />
Hardeman, Martha Mann, Samuel Hughes,<br />
Benjamin Greenberg<br />
P2.159 A Phase 1b Clinical Trial with<br />
Tolerogenic Dendritic Cells for Multiple<br />
Sclerosis and Neuromyelitis Óptica —Irati<br />
Zubizarreta, Daniel Benitez, Varea Sara, Joan<br />
Albert Arnaiz, Albert Saiz, Pablo Villoslada<br />
P2.160 Long-term Effect of<br />
Cyclosporine A in the Prophylaxis<br />
of Neuromyelitis Optica Spectrum<br />
Disorders —Takashi Kageyama, Katsuichi<br />
Miyamoto, Akihiko Ozaki, Mika Komori,<br />
Taro Okunomiya, Daisuke Kambe, Toshihiko<br />
Suenaga, Susumu Kusunoki, Sadayuki<br />
Matsumoto, Ryosuke Takahashi, Takayuki<br />
Kondo<br />
P2.161 Infliximab for Treatment<br />
Refractory Neuro-Behçet Syndrome —<br />
Burcu Zeydan, Ugur Uygunoglu, Sabahattin<br />
Saip, Onat Demirci, Emire Seyahi, Serdal<br />
Ugurlu, Vedat Hamuryudan, Aksel Siva, Orhun<br />
Kantarci<br />
P2.162 Induction of Autoimmune<br />
Encephalitis by Treatment with Ipilimumab<br />
and Nivolumab —David Benavides, Tanya<br />
Williams, Kelly-Ann Patrice, Dung Le, Evan<br />
Lipson, Ellen Mowry, John Probasco<br />
P2.163 Treatment of Anti-DPPX-<br />
Encephalitis Refractory to Corticosteroids,<br />
Plasma Exchange and Rituximab —<br />
Andrew Smith, Andrew Goodman, Andrew<br />
McKeon, Lawrence Samkoff<br />
P2.164 Infliximab for the Treatment<br />
of Neurosarcoidosis: The Mayo Clinic<br />
Experience —Derek Stitt, Allen Aksamit,<br />
James Utz<br />
P2.165 Rituximab for Refractory<br />
Myasthenia Gravis in a Pregnant<br />
Patient —Tarun Girotra, Nour Baki, Kavita<br />
Grover<br />
P2.166 Case Report: Improvement<br />
of GAD65-Associated Autoimmune<br />
Epilepsy with Testosterone Replacement<br />
Therapy —Melissa Heiry, Pegah Afra,<br />
Fumisuke Matsuo, John Greenlee, Stacey<br />
Clardy<br />
P2.167 A Case of Sarcoidosis<br />
with Improvement After Initiation of<br />
Natalizumab Therapy —Josef Gutman,<br />
Jerome Graber, David Dickoff<br />
MS and CNS Inflammatory Disease:<br />
MS Symptoms, Specific Symptoms<br />
Treatments, Co-morbidities, and Cost<br />
P2.168 Cognitive Impairment in Newly<br />
Diagnosed Multiple Sclerosis: Does It<br />
Differ Between Racial/Ethnic Groups? —<br />
Christopher Schroeder, Edlin Gonzales,<br />
Samantha Haraszti, Annette Langer-Gould<br />
P2.169 Clinical Response to<br />
Nabiximols (Sativex ® ) on Spasticity and<br />
Pain Is Paralleled by a Down-Regulation<br />
of Immune-Related Pathways in Multiple<br />
Sclerosis Patients —Filippo Martinelli<br />
Boneschi, Melissa Sorosina, laura ferre',<br />
Ferdinando Clarelli, Vittorio Martinelli,<br />
Federica Esposito, Giancarlo Comi<br />
P2.170 An Adaptive Computer-Based<br />
Cognitive Training Program Improves<br />
Cognitive Functioning in Adults with<br />
Multiple Sclerosis (MS): Results of a<br />
Double-Blind Randomized Active-Placebo-<br />
Controlled 12-Week Trial —Leigh Charvet,<br />
Jie Yang, Michael Shaw, Kathleen Sherman,<br />
Jianjin Xu, Lamia Haider, Lauren Krupp<br />
P2.171 Dialectical Behaviour Therapy<br />
Is an Effective Treatment for Depression<br />
and Anxiety in Multiple Sclerosis —<br />
Mervin Blair, Sascha Gill, Denise Deluca,<br />
Grace Ferreria, Rebecca King, Andrew Ekblad,<br />
Denise Bowman, Joshua Hanna, Kathy<br />
Smolewska, Erin Warriner, Sarah Morrow<br />
P2.172 Elevated Brain Temperature<br />
Is Associated with Worse Fatigue in<br />
Relapsing Remitting Multiple Sclerosis<br />
Patients —Victoria Leavitt, Alayar Kangarlu,<br />
Feng Liu, Claire Riley, James Sumowski<br />
P2.173 Multiple Sclerosis, Fatigue and<br />
Discordant Patient Reported Outcomes:<br />
Sleep Quality (Sleep-NeuroQoL),<br />
Neurological Disability and Depression —<br />
Mark Gudesblatt, Karl Wissemann, Myassar<br />
Zarif, Barbara Bumstead, Lori Fafard, Cynthia<br />
Sullivan, Jeffrey Wilken, Marijean Buhse,<br />
Daniel Golan<br />
P2.174 Aerobic Exercise Improves<br />
Fitness and Cognition in Relapsing<br />
Remitting Multiple Sclerosis —Rebecca<br />
Spain, Manoj Sammi, Bharti Garg, Rebecca<br />
Kingsland, Kerry Kuehl, William Rooney<br />
P2.175 Which Symptoms Correlate<br />
the Most to Health-Related Quality of Life<br />
(HRQoL) in MS? —Rivka Green, Ilya Kister<br />
P2.176 The Association of Pathological<br />
Laughing and Crying and Cognitive<br />
Impairment in Multiple Sclerosis —Joshua<br />
Hanna, Anthony Feinstein, Sarah Morrow<br />
P2.177 Successful Treatment of<br />
Paroxysmal Ataxia and Dysarthria in MS<br />
with Levitracetam —Shikha Goodwin,<br />
Adam Carpenter<br />
P2.178 Gender Identity Disorders<br />
and Multiple Sclerosis Risk: A National<br />
Record-Linkage Study —Julia Pakpoor,<br />
Clare Wotton, Klaus Schmierer, Gavin<br />
Giovannoni, Michael Goldacre<br />
P2.179 Assessment of Olfaction<br />
and Gustation in Multiple Sclerosis:<br />
Correlation with Cognition —Ozgul<br />
Ekmekci, Naila Alakbarova, Ayse Nur Yuceyar<br />
P2.180 Antidepressant Use in<br />
Association with Multiple Sclerosis<br />
Disease Modifying Therapy —Matthew<br />
Mirsky, Alexander Rae-Grant<br />
P2.181 Association of Disability<br />
Progression and Affective Disorders<br />
over Time in a Prospective 9 Year Follow<br />
Up Cohort of Patients with Multiple<br />
Sclerosis —Matthias Knop, Sandra<br />
Nischwitz, Marcus Ising, Hans Faber, Frank<br />
Weber<br />
P2.182 Improvement of the<br />
Spatiotemporal Parameters in Walking<br />
in Primary Progressive Patients Treated<br />
with Fampridine —Ines Gonzalez, Irene<br />
Pulido-Valdeolivas, David Gomez-Andres,<br />
Aida Orviz-Garcia, Andrea Montero-Atalaya,<br />
Juan Andres Martin-Gonzalo, Irene<br />
Rodriguez-Andonaegui, Estrella Rausell, Celia<br />
Oreja-Guevara<br />
P2.183 Sexual Dysfunction in Male<br />
Patients with Multiple Sclerosis —lorena<br />
garcia, Alba Velazquez, Elena Bellosta Diago,<br />
Sonia Santos, Cristina Iniguez<br />
P2.184 Psychological Growth and<br />
Benefit Finding in Multiple Sclerosis<br />
(MS) and Their Relationship to Symptom<br />
Burden —Allison Marziliano, Kathleen<br />
Sherman, Michael Shaw, Ariana Frontario,<br />
Leigh Charvet<br />
P2.185 Examining the Effects of<br />
Comorbidities on Disease-Modifying<br />
Therapy Use in Multiple Sclerosis —<br />
Tingting Zhang, Helen Tremlett, Stella Leung,<br />
Feng Zhu, Elaine Kingwell, John Fisk, Virender<br />
Bhan, Trudy Campbell, Nancy Yu, Ruth-Ann<br />
Marrie<br />
P2.186 Parkinson’s Disease in<br />
Multiple Sclerosis - A Population-Based,<br />
Nationwide Study in Denmark —Anja<br />
Thormann, Melinda Magyari, Nils Koch-<br />
Henriksen, Bjarne Laursen, Per Soelberg-<br />
Sorensen<br />
P2.187 Allergies Are Associated with<br />
Increased Disease Activity in Multiple<br />
Sclerosis —Camilo Diaz-Cruz, Alicia Chua,<br />
Brian Healy, Neda Sattarnezhad, Bonnie<br />
Glanz, Howard Weiner, Tanuja Chitnis<br />
P2.188 Persistent Use of<br />
Dalfampridine Extended Release on<br />
Healthcare Resource Utilization and Cost<br />
in Multiple Slerosis: A Claims Database<br />
Analysis —Stephen Krieger, Alexander<br />
Niyazov, Dendy Macaulay, Emi Terasawa, Eric<br />
Wu, Peter Aupperle, Amy Guo<br />
P2.189 Hereditary Neuropathy with<br />
Liability to Pressure Palsies (HNPP) and<br />
Multiple Sclerosis (MS) in the Same<br />
Patient: Coincidence or Link? —Nassima<br />
Baba-Ahmed, Aram Zabeti, Hani Kushlaf<br />
P2.190 Age-, Sex-, and Geographic<br />
Region-Specific Comorbidity in Patients<br />
with Multiple Sclerosis —Natalie Edwards,<br />
Amy Phillips, Julie Locklear<br />
P2.191 Suicide Ideation in Multiple<br />
Sclerosis —Aliza Ben-Zacharia<br />
P2.192 Sick Leave and Disability<br />
Pension in Patients with Multiple<br />
Sclerosis: A Longitudinal, Observational<br />
Study —Erik Landfeldt, Anna Castelo-<br />
Branco, Axel Svedbom, Emil Lofroth, Andrius<br />
Kavaliunas, Jan Hillert<br />
P2.193 Cost Effectiveness of Multiple<br />
Sclerosis Therapeutic Strategies for<br />
Achieving No Evidence of Disease<br />
Activity —Daniel Ontaneda, Olaisen Henry<br />
P2.194 Dynamic Hand Grip Objectively<br />
Measures Fatigue in Multiple Sclerosis<br />
(MS) and Improves with Transcranial<br />
Direct Current Stimulation (tDCS) —<br />
Raghav Malik, Margaret Kasschau, Michael<br />
Shaw, Michael Porter, Colleen Schwarz, Leigh<br />
Charvet<br />
P2.195 Effects of a Program Designed<br />
to Improve Self-Efficacy and Subsequent<br />
Effects on Decreasing Loneliness and<br />
Depression Among People with Multiple<br />
Sclerosis —Jennifer Kalina<br />
P2.196 Concepts Important for<br />
Multiple Sclerosis Patient Caregivers:<br />
Systematic Literature Review of<br />
Qualitative Studies —Sarah Naoshy, Jie<br />
Ting, Crystal Watson, Delphine Jurado,<br />
Catherine Acquadro, Isabelle Savre<br />
P2.197 Lower Socioeconomic Status Is<br />
Linked to Worse Disability in Persons with<br />
Multiple Sclerosis —James Sumowski,<br />
Maria Rocca, Victoria Leavitt, Alessandro<br />
Meani, Sarlota Mesaros, Jelena Drulovic,<br />
Paolo Preziosa, Giancarlo Comi, Massimo<br />
Filippi<br />
Headache: Therapeutics<br />
P2.198 Cost-Effectiveness of Initial<br />
Prophylactic Treatment of Chronic<br />
Migraine: Oral Medications Versus<br />
OnabotulinumtoxinA —Kristin Kelley, Anna<br />
Schoenbrunner, James Murphy<br />
P2.199 Short-Term Non-Invasive<br />
Vagus Nerve Stimulation (nVNS) for the<br />
Prevention of Menstrual Migraine —Licia<br />
Grazzi, Gabriella Egeo, Anna Padovan, Eric<br />
Liebler, Piero Barbanti<br />
50 2016 AAN Annual Meeting Abstract Listing
Change language